Cargando…

Acute leukaemia in children with Down syndrome in a low middle-income country

Down syndrome (DS) is the commonest chromosomal disorder and is considered to be the most common syndrome associated with acute leukaemia. The objective of this study was to determine the characteristics of acute leukaemia in children with DS in Pakistan. It was a retrospective, cohort study conduct...

Descripción completa

Detalles Bibliográficos
Autores principales: Ul-Ain, Rahat, Faizan, Mahwish, Anwar, Saadia, Riaz, Shazia, Ahmad, Alia, Zafar, Huma, Shamim, Wasila
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cancer Intelligence 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9116992/
https://www.ncbi.nlm.nih.gov/pubmed/35702410
http://dx.doi.org/10.3332/ecancer.2022.1374
_version_ 1784710231650992128
author Ul-Ain, Rahat
Faizan, Mahwish
Anwar, Saadia
Riaz, Shazia
Ahmad, Alia
Zafar, Huma
Shamim, Wasila
author_facet Ul-Ain, Rahat
Faizan, Mahwish
Anwar, Saadia
Riaz, Shazia
Ahmad, Alia
Zafar, Huma
Shamim, Wasila
author_sort Ul-Ain, Rahat
collection PubMed
description Down syndrome (DS) is the commonest chromosomal disorder and is considered to be the most common syndrome associated with acute leukaemia. The objective of this study was to determine the characteristics of acute leukaemia in children with DS in Pakistan. It was a retrospective, cohort study conducted over a 2-year period, and the data was analysed in SPSS 20.0 in terms of descriptive statistics. Nineteen DS patients with acute leukaemia were enrolled. The proportion of DS-acute leukaemia was found to be 1.84% among all cases of paediatric acute leukaemia. The mean age of presentation was 5.5 years ± 4.3 SD with a male to female ratio of 1.1:1. The precursor B-cell ALL was found in 13 (68.4%) and acute myeloid leukaemia was found in 6 (31.6%) patients of DS. Thirteen patients (68.4%) completed treatment, while 6 (31.6%) expired due to treatment-related toxicity. Mean overall survival was 38 months ± 5.34 SD. The status of diagnosis of DS before presentation with acute leukaemia was the only statistically significant factor associated with the outcome. Few distinct characteristics of DS-acute leukaemia have been found in our population. Treatment toxicity was the sole cause of treatment failure.
format Online
Article
Text
id pubmed-9116992
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Cancer Intelligence
record_format MEDLINE/PubMed
spelling pubmed-91169922022-06-13 Acute leukaemia in children with Down syndrome in a low middle-income country Ul-Ain, Rahat Faizan, Mahwish Anwar, Saadia Riaz, Shazia Ahmad, Alia Zafar, Huma Shamim, Wasila Ecancermedicalscience Research Down syndrome (DS) is the commonest chromosomal disorder and is considered to be the most common syndrome associated with acute leukaemia. The objective of this study was to determine the characteristics of acute leukaemia in children with DS in Pakistan. It was a retrospective, cohort study conducted over a 2-year period, and the data was analysed in SPSS 20.0 in terms of descriptive statistics. Nineteen DS patients with acute leukaemia were enrolled. The proportion of DS-acute leukaemia was found to be 1.84% among all cases of paediatric acute leukaemia. The mean age of presentation was 5.5 years ± 4.3 SD with a male to female ratio of 1.1:1. The precursor B-cell ALL was found in 13 (68.4%) and acute myeloid leukaemia was found in 6 (31.6%) patients of DS. Thirteen patients (68.4%) completed treatment, while 6 (31.6%) expired due to treatment-related toxicity. Mean overall survival was 38 months ± 5.34 SD. The status of diagnosis of DS before presentation with acute leukaemia was the only statistically significant factor associated with the outcome. Few distinct characteristics of DS-acute leukaemia have been found in our population. Treatment toxicity was the sole cause of treatment failure. Cancer Intelligence 2022-04-13 /pmc/articles/PMC9116992/ /pubmed/35702410 http://dx.doi.org/10.3332/ecancer.2022.1374 Text en © the authors; licensee ecancermedicalscience. https://creativecommons.org/licenses/by/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0 (https://creativecommons.org/licenses/by/4.0/) ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research
Ul-Ain, Rahat
Faizan, Mahwish
Anwar, Saadia
Riaz, Shazia
Ahmad, Alia
Zafar, Huma
Shamim, Wasila
Acute leukaemia in children with Down syndrome in a low middle-income country
title Acute leukaemia in children with Down syndrome in a low middle-income country
title_full Acute leukaemia in children with Down syndrome in a low middle-income country
title_fullStr Acute leukaemia in children with Down syndrome in a low middle-income country
title_full_unstemmed Acute leukaemia in children with Down syndrome in a low middle-income country
title_short Acute leukaemia in children with Down syndrome in a low middle-income country
title_sort acute leukaemia in children with down syndrome in a low middle-income country
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9116992/
https://www.ncbi.nlm.nih.gov/pubmed/35702410
http://dx.doi.org/10.3332/ecancer.2022.1374
work_keys_str_mv AT ulainrahat acuteleukaemiainchildrenwithdownsyndromeinalowmiddleincomecountry
AT faizanmahwish acuteleukaemiainchildrenwithdownsyndromeinalowmiddleincomecountry
AT anwarsaadia acuteleukaemiainchildrenwithdownsyndromeinalowmiddleincomecountry
AT riazshazia acuteleukaemiainchildrenwithdownsyndromeinalowmiddleincomecountry
AT ahmadalia acuteleukaemiainchildrenwithdownsyndromeinalowmiddleincomecountry
AT zafarhuma acuteleukaemiainchildrenwithdownsyndromeinalowmiddleincomecountry
AT shamimwasila acuteleukaemiainchildrenwithdownsyndromeinalowmiddleincomecountry